Online citations, reference lists, and bibliographies.
← Back to Search

Analysis Of Protective And Nonprotective Monoclonal Antibodies Specific For Bordetella Pertussis Lipooligosaccharide.

R. Shahin, Josée Hamel, M. Leef, B. Brodeur
Published 1994 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
In this study, it has been determined that immunoglobulin G1 (IgG1) and IgG3 monoclonal antibodies directed to the lipooligosaccharide A of Bordetella pertussis were able to protect mice from fatal aerosol infection. No correlation was found between the bactericidal activity in vitro in the presence of complement and the protection in mice, since a bactericidal IgG3 did not elicit protection. In addition, no significant difference in protective capacity was observed with bactericidal and nonbactericidal IgG1 antibodies, indicating that bactericidal activity is not a requirement for protection mediated by certain anti-lipooligosaccharide A antibodies. A reduction in protection in C5-deficient mice was observed, suggesting a significant role for complement in certain host defense mechanisms against B. pertussis infection.



This paper is referenced by
10.1038/s41598-018-30558-8
Detection of opsonizing antibodies directed against a recently circulating Bordetella pertussis strain in paired plasma samples from symptomatic and recovered pertussis patients
E. S. Hovingh (2018)
10.1016/0952-7915(95)80101-4
Bibliography of the current world literature
(1995)
10.1016/j.micinf.2018.02.002
Diversion of complement-mediated killing by Bordetella.
Anaïs Thiriard (2018)
10.1073/pnas.1324149111
Toward a new vaccine for pertussis
J. Robbins (2014)
10.1128/IAI.74.5.2619-2627.2006
Maternal Immunity Provides Protection against Pertussis in Newborn Piglets
S. Elahi (2006)
10.4049/jimmunol.1700742
Erythroid Suppressor Cells Compromise Neonatal Immune Response against Bordetella pertussis
Garett Dunsmore (2017)
Pertactin-Regulated Factors , Including bvg on Cytotoxicity to Macrophages Is Dependent-Mediated Bordetella bronchiseptica
C. B. Forde (1999)
10.1084/JEM.191.11.1841
Protective Immunity to Bordetella pertussis Requires Both B Cells and Cd4+ T Cells for Key Functions Other than Specific Antibody Production
M. Leef (2000)
10.1128/IAI.63.4.1195-1200.1995
Adjuvanticity and protective immunity elicited by Bordetella pertussis antigens encapsulated in poly(DL-lactide-co-glycolide) microspheres.
R. Shahin (1995)
10.1128/CDLI.8.5.1015-1017.2001
Serum Immunoglobulin G Antibody Responses to Bordetella pertussis Lipooligosaccharide and B.parapertussis Lipopolysaccharide in Children with Pertussis and Parapertussis
B. Trollfors (2001)
PURIFICATION AND PROTECTIVE EFFICACY OF RE- NATURED C-TERMINAL DOMAIN (P.30) OF PERTACTIN AUTOTRANSPORTER PROTEIN OF BORDETELLA PERTUSSIS
S. Bokhari (2008)
10.1074/jbc.M513904200
Complete Structures of Bordetella bronchiseptica and Bordetella parapertussis Lipopolysaccharides*
Andrew Z. Preston (2006)
10.1128/9781555815639.CH33
Evolution of Bordetella pertussis and Bordetella parapertussis as Deduced from Comparative Genome Analyses
A. Preston (2008)
10.1177/09680519010070040601
Invited review: The molecular genetics and role in infection of lipopolysaccharide biosynthesis in the Bordetellae
A. Preston (2001)
10.1016/J.TIM.2007.09.003
The benefits of using diverse animal models for studying pertussis.
S. Elahi (2007)
10.1128/IAI.01063-16
Protective Role of Passively Transferred Maternal Cytokines against Bordetella pertussis Infection in Newborn Piglets
S. Elahi (2017)
Bordetella pertussis Antibodies to Characterization of Human Bactericidal
A. Weiss (1998)
10.1084/JEM.186.11.1843
Atypical Disease after Bordetella pertussis Respiratory Infection of Mice with Targeted Disruptions of Interferon-γ Receptor or Immunoglobulin μ Chain Genes
B. Mahon (1997)
10.1016/S1286-4579(01)01421-6
Immunity to Bordetella pertussis.
K. Mills (2001)
10.1128/IAI.67.11.5972-5978.1999
Bordetella bronchiseptica-Mediated Cytotoxicity to Macrophages Is Dependent on bvg-Regulated Factors, Including Pertactin
C. B. Forde (1999)
10.1007/BF00201101
Antigenic analysis of the saccharide moiety of the lipooligosaccharide of Bordetella pertussis
B. Brodeur (2004)
Purification, formulation and characterisation of the adenylate cyclase toxin of Bordetella pertussis
A. Khosravani (2006)
10.1128/IAI.67.3.1424-1431.1999
Characterization of Human Bactericidal Antibodies to Bordetella pertussis
A. Weiss (1999)
Bordetella per tussis
A. Allen (2006)
10.1128/IAI.65.12.4904-4908.1997
Role of gamma interferon in natural clearance of Bordetella pertussis infection.
J. Barbić (1997)
10.1038/s41598-017-07938-7
CD71+ erythroid suppressor cells impair adaptive immunity against Bordetella pertussis
A. Namdar (2017)
10.1016/B978-012304220-0/50014-5
CHAPTER 13 – Bordetella
P. Cotter (2001)
10.1371/journal.pone.0109778
c-di-GMP Enhances Protective Innate Immunity in a Murine Model of Pertussis
S. Elahi (2014)
Semantic Scholar Logo Some data provided by SemanticScholar